GW
ABMD

GW & Wade’s Abiomed Inc ABMD Stock Holding History

GW & Wade’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-883
Closed -$213K – 253
2020
Q2 		$213K Buy
+883
New +$177K 0.02% 227
2019
Q3 		– Sell
-883
Closed -$230K – 242
2019
Q2 		$230K Hold
883
– – 0.02% 212
2019
Q1 		$252K Hold
883
– – 0.02% 203
2018
Q4 		$287K Buy
883
+1
+0.1% +$347 0.03% 181
2018
Q3 		$397K Sell
882
-118
-12% -$46.5K 0.04% 159
2018
Q2 		$409K Hold
1,000
– – 0.05% 160
2018
Q1 		$291K Buy
+1,000
New +$253K 0.03% 181

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GW & Wade's ABMD Position: Q3 2020 in Review

GW & Wade sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 883 shares — an estimated $213K sold.

GW & Wade first reported a position in ABMD in Q1 2018 and held it in 7 quarters. The position peaked at $409K in Q2 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • GW & Wade reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • GW & Wade sold 883 Abiomed Inc shares in Q3 2020, an estimated $213K.
  • GW & Wade first reported a position in Abiomed Inc in Q1 2018 and held it in 7 quarters.
  • GW & Wade's Abiomed Inc position peaked at $409K in Q2 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on GW & Wade's 13F filing for Q3 2020, filed 9 Nov 2020.